Why Google and Novartis are teaming up | Pharmaguy's Insights Into Drug Industry News | Scoop.it
First there was Google Glass. Now, there might be Google contact lenses.


They're working on smart lenses that will be able to monitor blood sugar levels for diabetics through the natural tears in our eyes.  


Google and Novartis also say they’re developing another lens that can auto-focus the eye. It could help with reading, because as the eye ages, it’s harder to see things up close.   


The two companies complement each other pretty well: Google doesn’t need any money from Novartis, while Novartis can help Google navigate the clinical and regulatory side of things.


“They need more the expertise in terms of running clinical trials, getting approval from the FDA, and then marketing after approval,” says John Mack, who follows the pharmaceutical industry as publisher of "Pharma Marketing News."